Solvonis Therapeutics plc
SVNS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £757 | £155 | £1,640 | £598 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £71 | £43 | £43 |
| Inventory | £0 | £51 | £187 | £0 |
| Other Curr. Assets | £58 | £43 | £330 | £122 |
| Total Curr. Assets | £815 | £314 | £2,157 | £740 |
| Property Plant & Equip (Net) | £0 | £39 | £701 | £310 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £2,068 | £2,068 | £2,068 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £300 | £13 | £13 | £12 |
| Total NC Assets | £2,388 | £2,120 | £2,782 | £2,390 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £3,203 | £2,434 | £4,939 | £3,130 |
| Liabilities | – | – | – | – |
| Payables | £83 | £159 | £185 | £841 |
| Short-Term Debt | £0 | £12 | £4 | £950 |
| Tax Payable | £0 | £22 | £23 | £39 |
| Deferred Revenue | £0 | £93 | £41 | £0 |
| Other Curr. Liab. | £36 | £122 | £137 | £527 |
| Total Curr. Liab. | £119 | £386 | £367 | £2,318 |
| LT Debt | £0 | £22 | £18 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £22 | £18 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £34 | £22 | £0 |
| Total Liabilities | £119 | £408 | £385 | £2,318 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £2,233 | £41 | £41 | £7 |
| Retained Earnings | -£10,555 | -£8,965 | -£5,845 | -£3,140 |
| AOCI | £0 | £3,949 | £3,357 | £3,003 |
| Other Equity | £11,406 | £14,002 | £7,858 | £3,945 |
| Total Equity | £3,084 | £2,026 | £4,554 | £812 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £3,203 | £2,434 | £4,939 | £3,130 |
| Net Debt | -£757 | -£121 | -£1,618 | £352 |